The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Cancer Education
Explore expert insights on the fundamentals of cancer, including how it develops, key risk factors, prevention strategies, and treatment options. This section also highlights cancer awareness months and related observance days and weeks. Commentaries from our network of oncology professionals shed light on critical issues that require greater attention across the cancer care and research continuum.
Is Choosing Palliative Care Giving Up?
By Matthew Meranda, DO
Palliative care isn’t giving up—it’s a compassionate, patient-centered specialty focused on improving quality of life for those facing serious illness.
Is Choosing Palliative Care Giving Up?
By Matthew Meranda, DO
Palliative care isn’t giving up—it’s a compassionate, patient-centered specialty focused on improving quality of life for those facing serious illness.
Is Choosing Palliative Care Giving Up?
By Matthew Meranda, DO
Palliative care isn’t giving up—it’s a compassionate, patient-centered specialty focused on improving quality of life for those facing serious illness.
What The FDA’s Crackdown On Synthetic Food Dyes Could Mean For Cancer Prevention
By The Cancer News Team
The FDA’s decision to phase out synthetic food dyes could significantly reduce cancer risk by eliminating petroleum-based additives linked to DNA damage and tumor growth.
What The FDA’s Crackdown On Synthetic Food Dyes Could Mean For Cancer Prevention
By The Cancer News Team
The FDA’s decision to phase out synthetic food dyes could significantly reduce cancer risk by eliminating petroleum-based additives linked to DNA damage and tumor growth.
What The FDA’s Crackdown On Synthetic Food Dyes Could Mean For Cancer Prevention
By The Cancer News Team
The FDA’s decision to phase out synthetic food dyes could significantly reduce cancer risk by eliminating petroleum-based additives linked to DNA damage and tumor growth.
Best of ASCO Seattle 2025: Key Hematologic Cancer Updates on Myelodysplastic Syndromes and Leukemia
By The Cancer News Team
Binaytara’s Best of ASCO Seattle 2025 highlighted the latest updates in hematologic malignancies, including new therapies for leukemia and myelodysplastic syndromes.
Best of ASCO Seattle 2025: Key Hematologic Cancer Updates on Myelodysplastic Syndromes and Leukemia
By The Cancer News Team
Binaytara’s Best of ASCO Seattle 2025 highlighted the latest updates in hematologic malignancies, including new therapies for leukemia and myelodysplastic syndromes.
Best of ASCO Seattle 2025: Key Hematologic Cancer Updates on Myelodysplastic Syndromes and Leukemia
By The Cancer News Team
Binaytara’s Best of ASCO Seattle 2025 highlighted the latest updates in hematologic malignancies, including new therapies for leukemia and myelodysplastic syndromes.